Scientific Programme

New Antiviral Therapies

Back

Update on AB-729 and AB-836, an siRNA and capsid inhibitor currently in development for the treatment of chronic hepatitis B infection – Dr. Gaston Picchio

31 May 2022
3.20pm – 3.40pm